Cargando…

c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: c-Met has been recognized as an important therapeutic target in gastric cancer, but the prognostic property of the c-Met status is still unclear. We aimed to characterize the prognostic effect of c-Met by systematic review and meta-analysis. METHODS: We identified 15 studies assessing su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shan, Yu, Yiyi, Zhao, Naiqing, Cui, Jianlan, Li, Wei, Liu, Tianshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817069/ https://www.ncbi.nlm.nih.gov/pubmed/24223894 http://dx.doi.org/10.1371/journal.pone.0079137

Ejemplares similares

The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials
por: Cui, Jianlan, et al.
Publicado: (2013)

FOXO3a promotes gastric cancer cell migration and invasion through the induction of cathepsin L
por: Yu, Shan, et al.
Publicado: (2016)

Consideration in Selection of the Control Group in Diagnostic Tests
por: Cui, Jianlan, et al.
Publicado: (2012)

Urinary cMet as a prognostic marker in immunoglobulin A nephropathy
por: An, Jung Nam, et al.
Publicado: (2020)

Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis
por: Peng, Zhi, et al.
Publicado: (2014)

Phase I study of adjuvant chemotherapy with nab‐paclitaxel and S‐1 for stage III Lauren's diffuse‐type gastric cancer after D2 resection (NORDICA study)
por: Cui, Yuehong, et al.
Publicado: (2022)

Soluble c-Met Is a Reliable and Sensitive Marker to Detect c-Met Expression Level in Lung Cancer
por: Lv, Huilai, et al.
Publicado: (2015)

Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study
por: Zhang, Lingyun, et al.
Publicado: (2022)

Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer
por: Zhang, Zhening, et al.
Publicado: (2023)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
por: Yu, Shan, et al.
Publicado: (2020)

Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis
por: Peng, Jifeng, et al.
Publicado: (2016)

Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)

Study on the expression of c-Met in gastric cancer and its correlation with preoperative serum tumor markers and prognosis
por: Zhang, Zhengchao, et al.
Publicado: (2022)

IntegrinB5 upregulated by HER2 in gastric cancer: a promising biomarker for liver metastasis
por: Li, Qian, et al.
Publicado: (2020)

Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma
por: Wu, Ju-gang, et al.
Publicado: (2014)

Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study
por: Li, Qian, et al.
Publicado: (2016)

Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells
por: Park, Chi Hoon, et al.
Publicado: (2016)

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases
por: Yan, Shunchao, et al.
Publicado: (2015)

Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2018)

c-Met as a new marker of cellular senescence
por: Boichuck, Maria, et al.
Publicado: (2019)

c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
por: Lux, Alexander, et al.
Publicado: (2019)

The prognostic value of HGF-c-MET signaling pathway in Gastric Cancer: a study based on TCGA and GEO databases
por: Wang, Chao, et al.
Publicado: (2020)

Mining the role of angiopoietin‐like protein family in gastric cancer and seeking potential therapeutic targets by integrative bioinformatics analysis
por: Tang, Cheng, et al.
Publicado: (2020)

Clinicopathological and prognostic significance of c-Met overexpression in breast cancer
por: Zhao, Xixi, et al.
Publicado: (2017)

A Meta-Analysis: Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer Patients Treated with 5-Fu Based Chemotherapy Predicts Serious Hematologic Toxicity but Not Prognosis
por: Tang, Cheng, et al.
Publicado: (2018)

Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation
por: Liu, Ruiqi, et al.
Publicado: (2018)

The Role of cMET in Gastric Cancer—A Review of the Literature
por: Van Herpe, Filip, et al.
Publicado: (2023)

MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit
por: Jardim, Denis L. Fontes, et al.
Publicado: (2014)

Establishment of a Prognostic Signature of Stromal/Immune-Related Genes for Gastric Adenocarcinoma Based on ESTIMATE Algorithm
por: Yu, Shan, et al.
Publicado: (2021)

Volumetric parameters on (18)F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET
por: Liu, Guobing, et al.
Publicado: (2019)

Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis
por: Pyo, Jung-Soo, et al.
Publicado: (2016)

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
por: Miyamoto, M, et al.
Publicado: (2011)

Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition
por: Cui, Yuehong, et al.
Publicado: (2016)

Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study
por: Li, Wei, et al.
Publicado: (2019)

RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients
por: Pereira, Marina Alessandra, et al.
Publicado: (2021)

Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis
por: Vsiansky, Vit, et al.
Publicado: (2018)

Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020)

Prognostic Value of Perineural Invasion in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Deng, Jing, et al.
Publicado: (2014)

Human chorionic gonadotropin promotes cell proliferation through the activation of c-Met in gastric cancer cells
por: Zhao, Rui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7465od4k7ndl0oaiglm1va4sc2